title: Retinoic acid signaling is required for proper morphogenesis of mammary gland.
abstract: Retinoic acid (RA), a bioactive chemical compound synthesized from dietary derived vitamin A, has been successfully used as a chemopreventive and chemotherapeutic agent through the regulation of cell proliferation, differentiation, and apoptosis acting via the retinoic acid receptors. Despite two decades of research on the function of retinoic acid, the physiological role of RA in mammary gland development is still not well characterized. In this report, we demonstrate that RA is required for proper morphogenesis of mouse mammary gland in a novel transgenic mouse model system. It was found that inhibition of RA signaling in vivo leads to excessive mammary ductal morphogenesis through upregulation of cyclin D1 and MMP-3 expression. Furthermore, we show that the transgene-induced excessive branching morphogenesis could be reversed by treatment with RA, demonstrating the direct physiological effect of RA signaling in vivo. In addition, we demonstrate that excessive branching morphogenesis in the transgenic mammary gland are cell-autonomous and do not require stromal signals within the transgenic mammary gland. Finally, we provide evidence suggesting that retinoic acid signaling is required for appropriate mammary gland differentiation. Collectively, our data indicate for the first time that retinoic acid signaling is required to maintain the homeostasis of mammary gland morphogenesis.
authors.affiliation: Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA. wangya@kci.wayne.edu
authors.forename: Y Alan
authors.initials: YA
authors.lastname: Wang
authors.forename: Kate
authors.initials: K
authors.lastname: Shen
authors.forename: Yaolin
authors.initials: Y
authors.lastname: Wang
authors.forename: S C
authors.initials: SC
authors.lastname: Brooks
mesh_terms: D000818:Animals; D049109:Cell Proliferation; D019938:Cyclin D1 / Q000378:metabolism; D018507:Gene Expression Regulation, Developmental; D007150:Immunohistochemistry; D008321:Mammary Glands, Animal / Q000196:embryology*; D019278:Matrix Metalloproteinase 3 / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D009024:Morphogenesis / Q000187:drug effects / Q000502:physiology*; D018168:Receptors, Retinoic Acid / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*; D014212:Tretinoin / Q000378:metabolism* / Q000494:pharmacology / Q000502:physiology
chemical_list: D018168:Receptors, Retinoic Acid; D019938:Cyclin D1; D014212:Tretinoin; D019278:Matrix Metalloproteinase 3